Validation is an obstacle to implementing technology. A streamlined approach is necessary.
With the heightened supplier scrutiny, it’s time to reevaluate your supplier quality program.
Before accepting money, the following is a guide to your due diligence process.
The device will no longer be available after December 31, 2018.
When it comes to adverse event reporting, the FDA does not grant exemptions.
Many considerations should not be overlooked.
After one year into the transition period, it is clear that manufacturers are not where they need to be in meeting the compliance deadline.
How simple labeling changes can drive big results for medical device manufacturers.
In pursuit of the almighty dollar, this case involves the smuggling of lamb fat.
Think outside of the box and approach your QMS with passion and creativity.